Research Funding

Acute to Chronic Pain Signatures (A2CPS)

Title NIH Guide RFA Number Common Fund Contact Application
Receipt Date
Clinical Coordination Center for Common Fund Acute to Chronic Pain Signatures (A2CPS) Program (U24 Clinical Trial Optional) 8/24/18 RFA-RM-18-035

Linda Porter, Ph.D.
301-435-7572
porterl@ninds.nih.gov

Letter of Intent: 9/24/18
Application Due Date:
10/24/18

Multisite Clinical Center Common Fund Acute to Chronic Pain Signatures Program: Acute Peri-operative Pain (UM1 Clinical Trial Optional) 8/24/18 RFA-RM-18-034

Linda Porter, Ph.D.
301-435-7572
porterl@ninds.nih.gov

Letter of Intent: 9/24/18
Application Due Date:
10/24/18
Multisite Clinical Center Common Fund Acute to Chronic Pain Signatures Program: Acute Pain from Musculoskeletal Trauma (UM1 Clinical Trial Optional) 8/24/18 RM-18-033

Linda Porter, Ph.D.
301-435-7572
porterl@ninds.nih.gov

Letter of Intent: 9/24/18
Application Due Date:
10/24/18
Omics Data Generation Centers (ODGCs) for Common Fund Acute to Chronic Pain Signatures Program (U54 Clinical Trial Optional) 8/24/18 RM-18-032

John Satterlee, Ph.D.
301-435-1020
satterleej@nida.nih.gov 

Letter of Intent: 9/24/18
Application Due Date:
10/24/18
Data Integration and Resource Center (DIRC) for Common Fund Acute to Chronic Pain Signatures Program (U54 Clinical Trial Optional) 8/24/18 RM-18-031

John Satterlee, Ph.D.
301-435-1020
satterleej@nida.nih.gov

Letter of Intent: 9/24/18
Application Due Date:
10/24/18

Extracellular RNA Communication

Title NIH Guide RFA Number Common Fund Contact Application
Receipt Date

Limited competition: Data Management and Resource Repository (DMRR) on Extracellular RNA (U54 Clinical Trial Not Allowed)

8/6/2018 RFA-RM-18-026 John Satterlee
satterleej@nida.nih.gov 
301-435-1020
Letter of Intent:
9/23/2018
Receipt Date:
10/23/2018
Advancing Extracellular RNA (exRNA) Communication Research: Improved Isolation and Analysis of exRNA-Carrier Subclasses (UG3/UH3 Clinical Trial Not Allowed) 8/6/2018 RFA-RM-18-027 Kevin Howcroft
Howcrofk@mail.nih.gov
240-276-6229
Letter of Intent:
9/23/2018
Receipt Date:
10/23/2018
Advancing Extracellular RNA (exRNA) Communication Research: Towards Single Extracellular Vesicle (EV) Sorting, Isolation, and Analysis of Cargo (UG3/UH3 Clinical Trial Not Allowed) 8/6/2018 RFA-RM-18-028 Danilo A. Tagle
Danilo.Tagle@nih.gov
301-594-8064
Letter of Intent:
9/23/2018
Receipt Date:
10/23/2018

Gabriella Miller Kids First

Title NIH Guide RFA Number Common Fund Contact Application
Receipt Date

Genome Sequencing Center for the Gabriella Miller Kids First Pediatric Research Program (U24 Clinical Trial Not Allowed)

7/23/2018 RFA-RM-18-030 James Coulombe
CoulombeJ@mail.nih.gov
301-451-1390
Letter of Intent:
9/30/2018
Receipt Date:
10/31/2018

Glycoscience

Title NIH Guide RFA Number Common Fund Contact Application
Receipt Date

Novel and Innovative Tools to Facilitate Identification, Tracking, Manipulation, and Analysis of Glycans and their Functions (U01 Clinical Trial Not Allowed)

8/10/2018 RFA-RM-18-036 Karl E. Krueger
kruegerk@mail.nih.gov
240-276-7026 
Letter of Intent: 30 days 
before
receipt date
Receipt date: 10/29/18
Innovative Adaptations to Simplify Existing Technologies for Manipulation and Analysis of Glycans (U01 Clinical Trial Not Allowed) 8/10/2018 RFA-RM-18-037 Karl E. Krueger
kruegerk@mail.nih.gov
240-276-7026
Letter of Intent: 30 days 
before
receipt date
Receipt date: 10/29/18

High-Risk Research: NIH Director's Early Independence Award Program

Title NIH Guide RFA Number Common Fund Contact Application
Receipt Date

2019 NIH Director's Early Independence Award (DP5)

3/26/2018 RFA-RM-18-010 Ravi Basavappa
earlyindependence@mail.nih.gov
(301) 435-7204
Letter of Intent:
8/27/2018
Receipt Date:
9/27/2018
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) 8/22/2018 PA-18-906 Ravi Basavappa
earlyindependence@mail.nih.gov
(301) 435-7204
 
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed) 1/25/2018 PA-18-592 Ravi Basavappa
earlyindependence@mail.nih.gov
301 435-7204
 

High-Risk Research: NIH Director's New Innovator Award Program

Title NIH Guide RFA Number Common Fund Contact Application
Receipt Date
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) 8/22/2018 PA-18-906 Ravi Basavappa
NewInnovatorAward@mail.nih.gov
(301) 435-7204
 
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed) 1/25/2018 PA-18-592 Ravi Basavappa
NewInnovatorAward@mail.nih.gov
301 435-7204
 


High-Risk Research: NIH Director's Pioneer Award Program

Title NIH Guide RFA Number Common Fund Contact Application
Receipt Date
2019 NIH Director's Pioneer Award Program (DP1 Clinical Trial Optional) 4/23/2018 RFA-RM-18-007 Dr. Ravi Basavappa
PioneerAwards@mail.nih.gov 
301 435-7204
9/14/2018
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) 8/22/2018 PA-18-906 Ravi Basavappa
PioneerAwards@mail.nih.gov
(301) 435-7204
 
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed) 1/25/2018 PA-18-592 Ravi Basavappa
PioneerAwards@mail.nih.gov
301 435-7204
 


High-Risk Research: NIH Director's Transformative Award Program

Title NIH Guide RFA Number Common Fund Contact Application
Receipt Date
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) 8/22/2018 PA-18-906 Ravi Basavappa
Transformative_Awards@mail.nih.gov
(301) 435-7204
 
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed) 1/25/2018 PA-18-592 Ravi Basavappa
Transformative_Awards@mail.nih.gov
(301) 435-7204
 

Illuminating the Druggable Genome

Title NIH Guide RFA Number Common Fund Contact Application
Receipt Date
Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed) 7/20/2018 RFA-RM-18-021 Christine Colvis
DruggableGenome@mail.nih.gov
301-451-3903
Letter of Intent:
9/26/2018
Receipt Date:
10/26/2018


Somatic Cell Genome Editing

Title NIH Guide RFA Number Common Fund Contact Application
Receipt Date
Notice of Pre-Application Webinar for the NIH Common Fund Somatic Cell Genome Editing program 8/01/2018 NOT-RM-18-020 P.J. Brooks
SCGEprogram@nih.gov
301-443-0513
Webinar will be held on 8/14/2018 at 12 PM ET
Development of Cell and Tissue Platforms to Detect Adverse Biological Consequences of Somatic Cell Genome Editing (U01 Clinical Trial Not Allowed) 7/25/2018 RFA-RM-18-022 John Sheridan
john.sheridan@nih.gov
301-435-0202
Letter of Intent:
9/18/2018
Receipt Date:
10/18/2018
Innovative Technologies to Deliver Genome Editing Machinery to Disease-relevant Cells and Tissues (UG3/UH3 Clinical Trial Not Allowed) 7/25/2018 RFA-RM-18-023 P.J. Brooks
pjbrooks@mail.nih.gov
301-443-0513
Letter of Intent:
9/18/2018
Receipt Date:
10/18/2018
Expanding the Human Genome Engineering Repertoire (U01 Clinical Trial Not Allowed) 7/25/2018 RFA-RM-18-024 Betty Poon
poonb@niaid.nih.gov
301-435-0202
Letter of Intent:
9/18/2018
Receipt Date:
10/18/2018
Innovative Technologies to Non-Invasively Monitor Genome Edited Cells In Vivo (UH2/UH3 Clinical Trial Not Allowed) 7/25/2018 RFA-RM-18-025 John Sheridan
john.sheridan@nih.gov
301-435-0202    
Letter of Intent:
9/18/2018
Receipt Date:
10/18/2018


Stimulating Peripheral Activity to Relieve Conditions (SPARC)

Title NIH Guide RFA Number Common Fund Contact Application
Receipt Date
SPARC Partnership Opportunity: Custom Arrangements for Device-Based Clinical Studies with Flexible Data and Intellectual Property Rights

Notice of Intent to Publish a Funding Opportunity Announcement for SPARC Clinical Studies of Peripheral and Spinal Neuromodulation Devices to Support New Indications and Human Functional Mapping (OT2 Clinical Trial Required)
6/29/2018 OTA-18-019 SPARC3 Program Team
SPARC_TPNI@mail.nih.gov
Mandatory Letter of Intent: 9/7/2018
Proposal: 10/15/2018


Past Funding Opportunities

This page last reviewed on September 24, 2018